Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the capital funding in support of the National Cancer Plan will be allocated; and what proportion of that funding will be spent on (a) diagnostic equipment and estate, (b) treatment capacity, including surgical hubs, operating theatres and associated infrastructure, (c) radiotherapy equipment and infrastructure and (d) cancer-specific digital infrastructure.
As set out in our 10 Year Capital Plan, approximately £5 billion of capital will be invested to increase secondary and emergency care capacity, modernise facilities, and support service transformation over this Spending Review period. This will help drive the return to National Health Service constitutional waiting time standards and improve urgent and emergency care performance.
The National Cancer Plan, published in February 2026, announced that £200 million in 2026 to 2027 has been ring fenced for Cancer Alliances to support them in making sustainable improvements to cancer delivery, as part of system development funding (SDF).
Cancer SDF is comprised of two allocations: place-based, provided to all Cancer Alliances on a fair-shares basis for local population needs; and targeted, provided to Cancer Alliances for targeted projects, with amounts determined by agreed run rates. Cancer Alliances must demonstrate how their spending reduces disparities and improves access to care. Allocations for 2027/28 and 2028/29 remain subject to NHS England’s planning.